Baseline reproducibility of B-Mode ultrasound imaging measurements of carotid intima media thickness: The multicenter isradipine diuretic atherosclerosis study (MIDAS)

M. Mercuri, M. G. Bond, Fenwick T Nichols, A. A. Carr, J. M. Flack, R. Byington, J. Raines

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

MIDAS is a double-blind, randomized, controlled clinical trial comparing the effects of isradipine with hydrochlorothiazide on the rate of changes in the progression of carotid intima media thickness in 883 asymptomatic primary hypertensives having ultrasonographic evidence of at least one uncomplicated carotid lesion. Estimates of carotid intima media thickness (IMT), a surrogate measure of atherosclerosis, are obtained with B-Mode ultrasound in the common, bifurcation, and internal carotid arteries, bilaterally. Examinations are performed at baseline and once every 6 months for 36 months. Major surrogate endpoints for atherosclerosis include severity, expressed as the Single Maximum IMT (Tmax) among the 12 arterial sites, and combined extent and severity, which is the overall Mean Maximum IMT (MeanMax) over 12 sites. Defining the reproducibility of outcome measurements is a primary objective in studies aimed at establishing whether medical intervention is effective in slowing the progression of atherosclerosis. In MIDAS baseline and final examinations, together with a randomly selected 20% quota of follow-up scans and readings, were blindly replicated. Examinations have been replicated on 878 of the 883 patients enrolled into the study. Baseline consistency of the measurements are presented as the mean arithmetic and absolute differences between two examinations and readings. The mean arithmetic and absolute differences for the MeanMax were -0.003 ± 0.156 and 0.12 mm, respectively. Variabilities were comparable for several other atherosclerosis endpoints with the greatest mean absolute difference noted for the Tmax (0.36 mm). Reproducibility of the intra- and intersonographer and reader performances ranged between 0.09 and 0.12 mm (absolute differences). There were not statistically significant differences between replicate examinations for any endpoint or for any measure of variability. These data show that measurements of IMT are highly consistent.

Original languageEnglish (US)
Pages (from-to)241-256
Number of pages16
JournalJournal of Cardiovascular Diagnosis and Procedures
Volume11
Issue number4
StatePublished - Dec 1 1993

Fingerprint

Isradipine
Carotid Intima-Media Thickness
Diuretics
Ultrasonography
Atherosclerosis
Reading
Hydrochlorothiazide
Common Carotid Artery
Internal Carotid Artery
Randomized Controlled Trials
Biomarkers

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Cardiology and Cardiovascular Medicine

Cite this

Baseline reproducibility of B-Mode ultrasound imaging measurements of carotid intima media thickness : The multicenter isradipine diuretic atherosclerosis study (MIDAS). / Mercuri, M.; Bond, M. G.; Nichols, Fenwick T; Carr, A. A.; Flack, J. M.; Byington, R.; Raines, J.

In: Journal of Cardiovascular Diagnosis and Procedures, Vol. 11, No. 4, 01.12.1993, p. 241-256.

Research output: Contribution to journalArticle

@article{424da7a276b9464fa08a4cb1a8e44d11,
title = "Baseline reproducibility of B-Mode ultrasound imaging measurements of carotid intima media thickness: The multicenter isradipine diuretic atherosclerosis study (MIDAS)",
abstract = "MIDAS is a double-blind, randomized, controlled clinical trial comparing the effects of isradipine with hydrochlorothiazide on the rate of changes in the progression of carotid intima media thickness in 883 asymptomatic primary hypertensives having ultrasonographic evidence of at least one uncomplicated carotid lesion. Estimates of carotid intima media thickness (IMT), a surrogate measure of atherosclerosis, are obtained with B-Mode ultrasound in the common, bifurcation, and internal carotid arteries, bilaterally. Examinations are performed at baseline and once every 6 months for 36 months. Major surrogate endpoints for atherosclerosis include severity, expressed as the Single Maximum IMT (Tmax) among the 12 arterial sites, and combined extent and severity, which is the overall Mean Maximum IMT (MeanMax) over 12 sites. Defining the reproducibility of outcome measurements is a primary objective in studies aimed at establishing whether medical intervention is effective in slowing the progression of atherosclerosis. In MIDAS baseline and final examinations, together with a randomly selected 20{\%} quota of follow-up scans and readings, were blindly replicated. Examinations have been replicated on 878 of the 883 patients enrolled into the study. Baseline consistency of the measurements are presented as the mean arithmetic and absolute differences between two examinations and readings. The mean arithmetic and absolute differences for the MeanMax were -0.003 ± 0.156 and 0.12 mm, respectively. Variabilities were comparable for several other atherosclerosis endpoints with the greatest mean absolute difference noted for the Tmax (0.36 mm). Reproducibility of the intra- and intersonographer and reader performances ranged between 0.09 and 0.12 mm (absolute differences). There were not statistically significant differences between replicate examinations for any endpoint or for any measure of variability. These data show that measurements of IMT are highly consistent.",
author = "M. Mercuri and Bond, {M. G.} and Nichols, {Fenwick T} and Carr, {A. A.} and Flack, {J. M.} and R. Byington and J. Raines",
year = "1993",
month = "12",
day = "1",
language = "English (US)",
volume = "11",
pages = "241--256",
journal = "Journal of Cardiovascular Ultrasonography",
issn = "1073-7774",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Baseline reproducibility of B-Mode ultrasound imaging measurements of carotid intima media thickness

T2 - The multicenter isradipine diuretic atherosclerosis study (MIDAS)

AU - Mercuri, M.

AU - Bond, M. G.

AU - Nichols, Fenwick T

AU - Carr, A. A.

AU - Flack, J. M.

AU - Byington, R.

AU - Raines, J.

PY - 1993/12/1

Y1 - 1993/12/1

N2 - MIDAS is a double-blind, randomized, controlled clinical trial comparing the effects of isradipine with hydrochlorothiazide on the rate of changes in the progression of carotid intima media thickness in 883 asymptomatic primary hypertensives having ultrasonographic evidence of at least one uncomplicated carotid lesion. Estimates of carotid intima media thickness (IMT), a surrogate measure of atherosclerosis, are obtained with B-Mode ultrasound in the common, bifurcation, and internal carotid arteries, bilaterally. Examinations are performed at baseline and once every 6 months for 36 months. Major surrogate endpoints for atherosclerosis include severity, expressed as the Single Maximum IMT (Tmax) among the 12 arterial sites, and combined extent and severity, which is the overall Mean Maximum IMT (MeanMax) over 12 sites. Defining the reproducibility of outcome measurements is a primary objective in studies aimed at establishing whether medical intervention is effective in slowing the progression of atherosclerosis. In MIDAS baseline and final examinations, together with a randomly selected 20% quota of follow-up scans and readings, were blindly replicated. Examinations have been replicated on 878 of the 883 patients enrolled into the study. Baseline consistency of the measurements are presented as the mean arithmetic and absolute differences between two examinations and readings. The mean arithmetic and absolute differences for the MeanMax were -0.003 ± 0.156 and 0.12 mm, respectively. Variabilities were comparable for several other atherosclerosis endpoints with the greatest mean absolute difference noted for the Tmax (0.36 mm). Reproducibility of the intra- and intersonographer and reader performances ranged between 0.09 and 0.12 mm (absolute differences). There were not statistically significant differences between replicate examinations for any endpoint or for any measure of variability. These data show that measurements of IMT are highly consistent.

AB - MIDAS is a double-blind, randomized, controlled clinical trial comparing the effects of isradipine with hydrochlorothiazide on the rate of changes in the progression of carotid intima media thickness in 883 asymptomatic primary hypertensives having ultrasonographic evidence of at least one uncomplicated carotid lesion. Estimates of carotid intima media thickness (IMT), a surrogate measure of atherosclerosis, are obtained with B-Mode ultrasound in the common, bifurcation, and internal carotid arteries, bilaterally. Examinations are performed at baseline and once every 6 months for 36 months. Major surrogate endpoints for atherosclerosis include severity, expressed as the Single Maximum IMT (Tmax) among the 12 arterial sites, and combined extent and severity, which is the overall Mean Maximum IMT (MeanMax) over 12 sites. Defining the reproducibility of outcome measurements is a primary objective in studies aimed at establishing whether medical intervention is effective in slowing the progression of atherosclerosis. In MIDAS baseline and final examinations, together with a randomly selected 20% quota of follow-up scans and readings, were blindly replicated. Examinations have been replicated on 878 of the 883 patients enrolled into the study. Baseline consistency of the measurements are presented as the mean arithmetic and absolute differences between two examinations and readings. The mean arithmetic and absolute differences for the MeanMax were -0.003 ± 0.156 and 0.12 mm, respectively. Variabilities were comparable for several other atherosclerosis endpoints with the greatest mean absolute difference noted for the Tmax (0.36 mm). Reproducibility of the intra- and intersonographer and reader performances ranged between 0.09 and 0.12 mm (absolute differences). There were not statistically significant differences between replicate examinations for any endpoint or for any measure of variability. These data show that measurements of IMT are highly consistent.

UR - http://www.scopus.com/inward/record.url?scp=0027894301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027894301&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027894301

VL - 11

SP - 241

EP - 256

JO - Journal of Cardiovascular Ultrasonography

JF - Journal of Cardiovascular Ultrasonography

SN - 1073-7774

IS - 4

ER -